Back

Baseline early diastolic mitral annular velocities and cancer therapy related cardiac dysfunction in HER2 therapy

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Predicting cancer therapy–related cardiac dysfunction: from artificial intelligence-enabled assessment to risk refinement Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Adib Chowdhury

Victorian Heart Hospital, Clayton (Australia)

6 More presentations in this session

Presentation thumbnail
Incremental value of TAPSE added to HFA-ICOS for ESC-Defined Cancer Therapy–Related Cardiac Dysfunction
Doctor N. Espinola-Zavaleta (Mexico City, MX)
Abstract Slides Video
Presentation thumbnail
Incidence and severity of cancer-therapy-related cardiac dysfunction during contemporary breast cancer therapy in a real-world cohort
Doctor V. Vinje (Nordbyhagen, NO)
Abstract Slides Video
Presentation thumbnail
Machine learning-driven probability of cancer therapy–related cardiac dysfunction in patients with non-Hodgkin lymphoma
Doctor D. Bursacovschi (Chisinau, MD)
Abstract Slides
Presentation thumbnail
Agreement between manual and AI-enhanced echocardiographic assessment of cancer therapy-related cardiac dysfunction in patients with early breast cancer
Mr E. Orstad (Nordbyhagen, NO)
Abstract Slides Video
Presentation thumbnail
Cardiopulmonary fitness and cancer therapy-related cardiac dysfunction defined by CMR: insights from the EMBRACE-MRI study
Doctor T. Goncalves (Toronto, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Predicting cancer therapy–related cardiac dysfunction: from artificial intelligence-enabled assessment to risk refinement

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Peak atrial longitudinal strain and time to peak longitudinal strain as markers of asymptomatic CTRCD in HER2-positive breast cancer: a prospective cohort study
20 June 2025
thumbnail
Congress Presentation
Baseline expression of miRNAs in HER-2+ early breast cancer patients as a predictor of cancer therapy-related cardiac dysfunction
1 September 2025
thumbnail
Congress Presentation
Anthracycline-induced cardiomyopathy: a second chance after cancer survival?
22 May 2023
thumbnail
Congress Presentation
Association of endothelin-1 levels and left ventricular diastolic function parameters in patients with lymphomas 12 months after polychemotherapy
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources